Mechanisms of anabolic therapies for osteoporosis

被引:492
作者
Canalis, Ernesto
Giustina, Andrea
Bilezikian, John P.
机构
[1] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA
[2] Univ Connecticut, Sch Med, Farmington, CT USA
[3] Univ Brescia, Dept Internal Med, Brescia, Italy
[4] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
关键词
D O I
10.1056/NEJMra067395
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antiresorptive agents help to restore skeletal balance by reducing bone turnover, primarily at the tissue level. Another therapeutic approach is to enhance bone formation with the use of anabolic agents, which differ fundamentally from antiresorptive drugs in their primary mechanism of action. This article reviews the mechanisms of polypeptide anabolic agents and strontium as potential therapeutic options for osteoporosis. Copyright © 2007 Massachusetts Medical Society.
引用
收藏
页码:905 / 916
页数:12
相关论文
共 80 条
[51]   Oral delivery of biologically active parathyroid hormone [J].
Leone-Bay, A ;
Sato, M ;
Paton, D ;
Hunt, AH ;
Sarubbi, D ;
Carozza, M ;
Chou, J ;
McDonough, J ;
Baughman, RA .
PHARMACEUTICAL RESEARCH, 2001, 18 (07) :964-970
[52]   Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling [J].
Li, XF ;
Zhang, YZ ;
Kang, HS ;
Liu, WZ ;
Liu, P ;
Zhang, JG ;
Harris, SE ;
Wu, DQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (20) :19883-19887
[53]   Prevalence of low femoral bone density in older US adults from NHANES III [J].
Looker, AC ;
Orwoll, ES ;
Johnston, CC ;
Lindsay, RL ;
Wahner, HW ;
Dunn, WL ;
Calvo, MS ;
Harris, TB ;
Heyse, SP .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (11) :1761-1768
[54]   Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease [J].
Loots, GG ;
Kneissel, M ;
Keller, H ;
Baptist, M ;
Chang, J ;
Collette, NM ;
Ovcharenko, D ;
Plajzer-Frick, I ;
Rubin, EM .
GENOME RESEARCH, 2005, 15 (07) :928-935
[55]  
Marie P J, 2006, Bone, V38, pS10
[56]  
Matsumoto T, 2004, J BONE MINER RES, V19, pS44
[57]   Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: Influence of GH replacement therapy [J].
Mazziotti, G ;
Bianchi, A ;
Bonadonna, S ;
Nuzzo, M ;
Cimino, V ;
Fusco, A ;
De Marins, L ;
Giustina, A .
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (04) :520-528
[58]   Glucocorticoid-induced osteoporosis: an update [J].
Mazziotti, Gherardo ;
Angeli, Alberto ;
Bilezikian, John P. ;
Canalis, Ernesto ;
Giustina, Andrea .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2006, 17 (04) :144-149
[59]   The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis [J].
Meunier, PJ ;
Roux, C ;
Seeman, E ;
Ortolani, S ;
Badurski, JE ;
Spector, TD ;
Cannata, J ;
Balogh, A ;
Lemmel, EM ;
Pors-Nielsen, S ;
Rizzoli, R ;
Genant, HK ;
Reginster, JY ;
Graham, J ;
Ng, KW ;
Prince, R ;
Prins, J ;
Seeman, E ;
Wark, J ;
Reginster, JY ;
Devogelaer, JP ;
Kaufman, JM ;
Raeman, F ;
Ziekenhuis, JP ;
Walravens, M ;
Pors-Nielsen, S ;
Beck-Nielsen, H ;
Charles, P ;
Sorensen, OH ;
Meunier, PJ ;
Aquino, JP ;
Benhamou, C ;
Blotman, F ;
Bonidan, O ;
Bourgeois, P ;
Dehais, J ;
Fardellone, P ;
Kahan, A ;
Kuntz, JL ;
Marcelli, C ;
Prost, A ;
Vellas, B ;
Weryha, G ;
Lemmel, EM ;
Felsenberg, D ;
Hensen, J ;
Kruse, HP ;
Schmidt, W ;
Semler, J ;
Stucki, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (05) :459-468
[60]   Evidence that anabolic effects of PTH on bone require IGF-I in growing mice [J].
Miyakoshi, N ;
Kasukawa, Y ;
Linkhart, TA ;
Baylink, DJ ;
Mohan, S .
ENDOCRINOLOGY, 2001, 142 (10) :4349-4356